BackLivongo Health Overview

Livongo Health EBIT

Latest ebit for LVGO: $-31M, below the Technology sector average of $4.7T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$660.00K

As of Jun 30, 2020

Annual EBIT (TTM)

-$30.94M

Trailing 12 months ending Jun 30, 2020

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Livongo Health (LVGO) FAQ

Livongo Health (LVGO) currently reports a EBIT of $-31M as of June 2020. That is below the Technology sector average of $4.7T. Use the charts on this page to explore Livongo Health's EBIT history and peer comparisons.

Livongo Health's EBIT of $-31M is lower than the Technology sector average of $4.7T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Livongo Health reported $-31M in EBIT as of June 2020. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-31M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $4.7T. From there, open related valuation or income-statement pages for Livongo Health, and consider following LVGO for alerts when major investors trade the stock.

Livongo Health is classified in the Technology sector. On EBIT, it currently shows $-31M versus a sector average near $4.7T. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing LVGO with unrelated industries.